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Introduction
The synthesis of thioglycosides has received considerable attention because of their activity as inhibitors1 and inducers of glycosidases,2 and also because of their use as glycosyl donors in the convergent synthesis of oligosaccharides. 3 Our laboratory has long been interested in the enzymes related to galactofuranose glycobiology, as galactofuranosyl residues are found in glycoconjugates of pathogenic microorganisms, such as the bacteria Mycobacterium tuberculosis and M. leprae,4,5 trypanosomatids like Trypanosoma cruzi and Leishmania,6-8 and fungi like Paracoccidioides brasilensis,9 but it is absent in mammalian cells. Therefore, the metabolic pathways involved in the biosynthesis and degradation of these microbial glycoconjugates, are attractive targets for the development of antimicrobial agents.
The enzymes responsible for the incorporation of galactofuranosyl units are the UDPgalactopyranosylmutase (EC 5.4.99.9),10-12 which converts UDP-Galp into the donor UDP-Galf, and a UDP-galactofuranosyltransferase, which is responsible for the incorporation of the sugar into the glycoconjugates. 13 The galactofuranosyl content of these glycoconjugates varies in vivo. For example the presence of β-D-Galf units in the mucins of the parasite T. cruzi depends on the strain.14 Also in T. cruzi, the main difference between the epimastigote form (the divisible form in the midgut of the insect host) and the trypomastigote form (the invasive form) is the Galf content in the glycoinositolphospholipids (GIPLs), the most abundant cell-surface molecules. 15 The degradation of the GIPLs could be involved in the parasite differentiation, what suggests that the inhibition of this metabolic pathway could prevent the evolution of the parasite to the infective form. These structural variations are attributed to the action of β-Dgalactofuranosidases.
Penicillium fellutanum is a non pathogenic fungus which produces an extracellular peptidophosphogalactomannan (pPGM) containing terminal β-D-Galf units. The percentage of this sugar decreases with the age of the culture as result of the action of an exo-β-Dgalactofuranosidase.16,17 The enzymes of this fungus related to galactofuranose glycoconjugates, have become model enzymes for us. We developed the synthesis of galactofuranose derivatives, as tools for their characterization, which once optimized could be used for the study of analogue enzymes in other microorganisms. Thus, we have synthesized chromogenic18,19 and radioactive substrates,20,21 and deoxygenated analogues of galactofuranosides. [22] [23] [24] We reported the synthesis of the alkyl, benzyl and aryl 1-thio-β-D-galactofuranosides 1-625 and nucleosides 7-826 (Figure 1 ), and their activities as exo-β-D-galactofuranosidase inhibitors have been proved. We also demonstrated that D-galactono-1,4-lactone (9) is and efficient inhibitor of such enzyme,25 and we developed an affinity chromatography system for the purification of β-D-galactofuranosidases by immobilization of 6, using lactone 9 for the elution of the enzyme. 27 We studied the influence of the inhibitors on the culture of Penicillium fellutanum,28 which produces a galactofuranosidase. 17 The development of such tools allowed us to detect β-D-galactofuranosidase activity in T. cruzi for the first time. 29 The growing interest in galactofuranose glycobiology prompted us to explore the inhibitory activities of new thioglycosides, such as heteroaryl 1-thio-β-D-galactofuranosides. We expect that these compounds could present an increased inhibitory activity as result of different interactions of the aglycon heteroatoms with the active site of the enzyme. Heteroaryl 1-thio-β-D-glycofuranosides were also synthesized by Plusquellec30,31 and they were used as donors for the synthesis of D-glycofuranosyl 1-phosphates, according to a procedure based on the "remote activation concept". 32 We now report the synthesis of heteroaryl 1-thio-β-Dgalactofuranosides and their activity as inhibitors of the exo-β-D-galactofuranosidase from P. fellutanum.
Results and Discussion
In contrast to glycosyltransferases, glycosidases are characterized for a broad substrate specificity. Compounds with considerable structural differences with respect to the natural substrates, can be hydrolysed with a characteristic kinetics,33 or act as inhibitors of the glycosidase.1 However, the exo-β-D-galactofuranosidase from P. fellutanum is highly specific, and its activity strongly depends on the size and polarity of the aglycons, as well as the glycon structure. For example, 4-nitrophenyl β-D-galactofuranoside (10, Figure 1) 18 is a good substrate for this enzyme (KM 0.31 mM),27 whereas 4-methylcoumarin-7-yl β-D-galactofuranoside (11) 19, with similar polarity but considerably bulkier, was not hydrolyzed by the enzyme.34 On the other hand, compound 6 was more potent than 5 as a galactofuranosidase inhibitor,25 proving the polarity dependence. The nucleoside 8 (IC50 0.10 mM) was ten times more active than the analogue 7, suggesting that the change in the flexibility of the imidazolidine ring facilitates the interaction with the active site of the enzyme. 26 The importance of the glycon structure was first evidenced by the fact that α-L-arabinofuranosides, the pentosyl homologues, were not hydrolyzed by the enzyme,17 and later we found that galactofuranosyl analogues deoxygenated at positions 2, 3 or 6 were resistant to the hydrolytic activity of the exo-β-D-galactofuranosidase, indicating that the hydroxyl groups at these positions are essential for the interaction with the enzyme. [22] [23] [24] Considering the specificity of this enzyme, we selected thiols with certain size for the synthesis of new thiogalactofuranosides as potential inhibitors. Thus, glycosylations of 2-pyridinethiol, 4-pyridinethiol, 1-methylimidazole-2-thiol, 5-methyl-1,3,4-thiadiazole-2-thiol, 2-pyrimidinethiol and 4,6-dimethyl-2-pyrimidinethiol were conducted.
We have previously described the preparation of alkyl, benzyl and aryl 1-thio-β-Dgalactofuranosides starting from 1,2,3,5,6-penta-O-benzoyl-α,β-D-galactofuranose (12) and SnCl4 as promoter of the glycosylation.25 However, attempted condensation of the selected thiols with 12, under the same conditions, led to a single crystalline product spectroscopically identified as 1,1'-disacharide 13 (Scheme 1). 35 This fact was attributed to the low solubility of the thiols in the reaction solvent (CH2Cl2). Therefore, the reaction was conducted in CH3CN, in which the thiols employed were completely soluble. In this case an excess of the Lewis acid was required, as the promoter underwent partial complexation by the aglycons.30-32 Under these conditions, 2-pyridinethiol, 4-pyridinethiol, 1-methylimidazole-2-thiol and 5-methyl-1,3,4-thiadiazole-2-thiol led to thioglycosides 14a-17a highly stereoselectively and in good yields. As 2-pyrimidinethiol and 4,6-dimethyl-2-pyrimidinethiol were not reactive under these conditions, BF3.OEt2 was employed to obtain thioglycosides 18a and 19a, although longer reaction times were required. The 1H NMR spectra of 14a and 16a-18a (Table 2) were similar to those previously described for per-O-benzoylated 1-thio-β-D-galactofuranosides,25 but with the anomerical signals significantly shielded downfield as effect of the heteroaryl aglycons. Compounds 14a and 16a-18a, showed vicinal coupling constants characteristic of conformations of the 1E-1T0-E0 segment of the pseudorotational itinerary, having the anomeric substituent in a quasi-axial position.37 In contrast, compounds 15a, 19a and the free thioglycosides 14b-16b, 18b and 19b, showed vicinal coupling constants suggesting a conformational shift towards the 3E-2T3-E3 region of the circle, with the anomeric sulfur atom in a quasi equatorial disposition.
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